There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Lam Research (LRCX – Research Report), Maxlinear (MXL – Research Report) and IMPINJ (PI – Research Report) with bullish sentiments.
Lam Research (LRCX)
In a report released today, Charles Shi from Needham maintained a Buy rating on Lam Research, with a price target of $1030.00. The company’s shares closed last Wednesday at $884.89.
According to TipRanks.com, Shi is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Lam Research with a $1006.36 average price target, a 10.9% upside from current levels. In a report issued on April 15, Evercore ISI also initiated coverage with a Buy rating on the stock with a $1200.00 price target.
See today’s best-performing stocks on TipRanks >>
Maxlinear (MXL)
In a report released today, David Williams from Benchmark Co. reiterated a Buy rating on Maxlinear, with a price target of $28.00. The company’s shares closed last Wednesday at $20.93.
According to TipRanks.com, Williams is a 4-star analyst with an average return of
Maxlinear has an analyst consensus of Moderate Buy, with a price target consensus of $24.00.
IMPINJ (PI)
Canaccord Genuity analyst Michael Walkley maintained a Buy rating on IMPINJ yesterday and set a price target of $160.00. The company’s shares closed last Wednesday at $120.91.
According to TipRanks.com, Walkley is a 5-star analyst with an average return of
IMPINJ has an analyst consensus of Strong Buy, with a price target consensus of $146.13, representing a 17.8% upside. In a report issued on April 15, Evercore ISI also initiated coverage with a Buy rating on the stock with a $160.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on LRCX:
- Lam Research Corporation Reports Financial Results for the Quarter Ended March 31, 2024
- Options Volatility and Implied Earnings Moves Today, April 24, 2024
- Is LRCX a Buy, Before Earnings?
- Lam Research upgraded to Buy from Neutral at B. Riley
- Lam Research price target raised to $1,030 from $900 at Needham
